Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Owen Scott Muir · Said 8 May 2024 · owen-1019

Quote

Not a forecast

“We don't have the published studies yet, we're just getting results at 12 weeks after the conclusion of the phase 2 trial for COMP360. However, here is what it looks like, and I really look forward to the results in subsequent phase 3 trials.”
· Post-traumatic stress disorder is real. New Compass Pathways data suggest psilocybin may be remarkably helpful. · substack post Paid

Compass Pathways released 12-week top-line phase 2 data on COMP360 (psilocybin) for PTSD (mean CAPS-5 reduction about 30 points, over half in remission). The author expects the program to proceed to phase 3 trials and anticipates their results.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements